Breast Cancer Metastatic
Showing 1 - 25 of 43
Her 2 Positive Breast Cancer, Breast Cancer Female, Breast Cancer Metastatic Trial in Boston (Sacituzumab Govitecan,
Not yet recruiting
- Her 2 Positive Breast Cancer
- +2 more
- Sacituzumab Govitecan
- +2 more
-
Boston, Massachusetts
- +1 more
Oct 25, 2023
Breast Cancer, Metastatic Breast Cancer, Breast Tumor Trial in Port Jefferson Station (SV-BR-1-GM, Cyclophosphamide, Interferon
Not yet recruiting
- Breast Cancer
- +4 more
- SV-BR-1-GM
- +4 more
-
Port Jefferson Station, New YorkNew York Cancers & Blood Specialists
Oct 2, 2023
Breast Cancer Stage IV, Breast Cancer Metastatic, Communication Trial in San Pedro Garza Garcia (Communication model)
Not yet recruiting
- Breast Cancer Stage IV
- +2 more
- Communication model
-
San Pedro Garza Garcia, Nuevo Leon, MexicoHospital Zambrano Hellion
Apr 28, 2023
Breast Cancer Metastatic, Leptomeningeal Metastasis Trial (Tucatinib Oral Tablet, Capecitabine tablets, Trastuzumab Injection)
Not yet recruiting
- Breast Cancer Metastatic
- Leptomeningeal Metastasis
- Tucatinib Oral Tablet
- +2 more
- (no location specified)
Mar 23, 2023
Breast Cancer Metastatic Trial in Spain (Irinotecan Hydrochloride)
Recruiting
- Breast Cancer Metastatic
- Irinotecan Hydrochloride
-
Badalona, Spain
- +19 more
Jan 18, 2023
Breast Cancer, Breast Cancer Metastatic Trial in Spain (Niraparib 100 MG, Aromatase Inhibitors)
Terminated
- Breast Cancer
- Breast Cancer Metastatic
- Niraparib 100 MG
- Aromatase Inhibitors
-
A Coruña, Spain
- +9 more
Jan 17, 2023
Breast Cancer Female, Breast Tumor Female Trial in United States (SV-BR-1-GM, INCMGA00012, Low dose cyclophosphamide)
Recruiting
- Breast Cancer
- +3 more
- SV-BR-1-GM
- +3 more
-
Newport Beach, California
- +9 more
Dec 8, 2022
Personalised Disease Monitoring in Metastatic Breast Cancer
Recruiting
- Breast Cancer Metastatic
- Estrogen Receptor-positive Breast Cancer
-
Gothenburg, Sweden
- +6 more
Dec 7, 2022
Pancreatic Adenocarcinoma Metastatic, BRCA1 Mutation, BRCA2 Mutation Trial in Boston, New York (Melphalan, BCNU, Vitamin B12B)
Recruiting
- Pancreatic Adenocarcinoma Metastatic
- +14 more
- Melphalan
- +5 more
-
Boston, Massachusetts
- +1 more
Dec 6, 2022
Screening For BCRL In Targeted Therapy For Breast Cancer
Recruiting
- Lymphedema
- +10 more
- Perometer
- SOZO device
-
Boston, MassachusettsMassachusetts General Hospital
Nov 21, 2022
Atezolizumab With Nab-paclitaxel for Triple-negative Stage IV
Completed
- Breast Cancer Metastatic
- Atezolizumab in combination with nab-paclitaxel
-
Roma, RM, ItalyPoliclinico A. Gemelli - IRCCS
Nov 2, 2022
Breast Cancer Metastatic, BRCA 1 Gene Mutation, BRCA 2 Gene Mutation Trial in Worldwide (Olaparib, Physician's choice chemo)
Active, not recruiting
- Breast Cancer Metastatic
- +2 more
- Olaparib
- Physician's choice chemotherapy
-
San Diego, California
- +171 more
Oct 10, 2022
Breast Cancer Metastatic Trial in United States (Paclitaxel, Pelareorep, Avelumab)
Active, not recruiting
- Breast Cancer Metastatic
- Paclitaxel
- +2 more
-
Miami, Florida
- +17 more
Sep 1, 2022
Breast Cancer Metastatic Trial in Worldwide (MCLA-128, Trastuzumab, Vinorelbine)
Active, not recruiting
- Breast Cancer Metastatic
- MCLA-128
- +3 more
-
Los Angeles, California
- +24 more
Aug 10, 2022
Breast Cancer Patients Trend Distinctive Regional
Completed
- Breast Cancer
- +4 more
-
Karachi, Sindh, PakistanSindh Institute of Urology and Transplantation
Jul 18, 2022
Breast Cancer Metastatic Trial in Beijing (TSL-1502 capsules(low dose), TSL-1502 capsules(high dose), Investigator's choice of
Not yet recruiting
- Breast Cancer Metastatic
- TSL-1502 capsules(low dose)
- +2 more
-
Beijing, ChinaCancer Hospital, Chinese Academy of Medical Sciences
Jun 13, 2022
Breast Cancer Metastatic Trial in Worldwide (Amcenestrant, Fulvestrant, Anastrozole)
Active, not recruiting
- Breast Cancer Metastatic
- Amcenestrant
- +5 more
-
Birmingham, Alabama
- +121 more
Apr 28, 2022
Breast Cancer Metastatic Trial in Sweden, United Kingdom (Palbociclib, Fulvestrant, Capecitabine)
Active, not recruiting
- Breast Cancer Metastatic
- Palbociclib
- +2 more
-
Göteborg, Sweden
- +8 more
Mar 29, 2022
Breast Cancer Metastatic Trial in Guangzhou (Tamoxifen Oral Product)
Completed
- Breast Cancer Metastatic
- Tamoxifen Oral Product
-
Guangzhou, Guangdong, ChinaSun Yat-sen University, Cancer Center
Mar 25, 2022
HR+ Metastatic Breast Cancer, Breast Cancer, Breast Cancer Metastatic Trial in Durham (GMI-1359)
Terminated
- HR+ Metastatic Breast Cancer
- +2 more
-
Durham, North CarolinaDuke University Medical Center
Mar 7, 2022